Lifelines for Health Newest Publication is Available Online - Issue #21, Winter 2023-24

Lifelines for Health 📗 - Newest Publication Available!
LifeLines for Health Winter 2023 issue now available electronically!

Lifelines for Health was once the first, ever-national publication for members of the bleeding disorders community with an inhibitor. Since 2019, Lifelines for Health has expanded to bleeding disorders with an emphasis on Rare Bleeding but also including inhibitors, women's health, ultra-rare conditions and the psychosocial aspects that come with them.

FEATURE:

How’s Your Quality of Life?

The bleeding disorder community has seen a lot of change already in 2024. We humans don’t like change because it presents us with uncertainty. Dr. Gary McClain shares some tips to embracing it
Take a peek!

Key Articles:

  • Innovative Approaches: For Hemophilia A & B with/without Inhibitors

    Curious about hemophilia studies? Hundreds of search results for hemophilia in the U.S. alone can be intimidating, so we delved into some with innovative mechanisms of action to point out.

  • Impact of COVID-19 on Education

     

    The pandemic had a profound impact on education, causing widespread disruptions and challenges. Children who rely on specialized services were especially hit
    hard, and trauma, in various forms, affected individuals differently - impacting attention, reactivity, and anxiety. Recovery is in motion through schools and resources, but these parent-pointers could be just what our students need to catch up at a more practical pace.

  • Employer-Sponsored Health Insurance: What You Need to Know

    Choosing the right health insurance, especially when managing chronic health conditions, is a complex task that requires careful consideration. More than half of the bleeding disorder community relies on employer-sponsored health insurance. Understanding the distinctions between these plans is crucial, as self-funded plans may not adhere to all Affordable Care Act provisions, potentially affecting prescription drug coverage and out-of-pocket costs.

Supported by:
Produced by CHES with sponsorship funding from Takeda, this newsletter is a valuable, educational, and inspirational tool for families and treaters alike. The newsletter publishes twice per year and distributed electronically and in print.

Clinical Trials

Find clinical trials in your area.

CHES is not responsible for claims, info, or advice given on this site.

 

Notifications

Sign up for your favorite events.

  • Receive periodic info on programs including dates, locations, and open registration.

  • Or update your preferences if you've already signed up for notifications.

 

CHES Foundation, Inc.
nSpiration Through Education
84 Beach Street, Middleboro MA 02346
Ph: 781.878.8561